XML 133 R93.htm IDEA: XBRL DOCUMENT v3.8.0.1
Share-Based Payments - Summary Details of BSA2 (Detail)
12 Months Ended
Jan. 20, 2019
EUR (€)
€ / shares
Dec. 31, 2017
Dec. 15, 2017
€ / shares
Dec. 05, 2017
€ / shares
Dec. 31, 2016
Dec. 31, 2015
Disclosure of terms and conditions of share-based payment arrangement [line items]            
Number of options granted     8,300 625,200    
Share entitlement per BSA2 | € / shares     € 1 € 1    
BSA 2 [Member]            
Disclosure of terms and conditions of share-based payment arrangement [line items]            
Number of options granted   0     0 0
Board of Director [Member] | BSA 2 [Member]            
Disclosure of terms and conditions of share-based payment arrangement [line items]            
Vesting period (years) 0 years          
Plan expiration date Jan. 20, 2019          
Number of options granted 4,822          
Share entitlement per BSA2 | € / shares € 15          
Exercise price (in euros) € 65          
Valuation method used            
Grant date share fair value (in euros) € 70          
Expected volatility 40.00%          
Average life of BCE2010 (in years) 0          
Discount rate 2.71%          
Expected dividends 0.00%          
Fair value per BSA2 (in euros) € 29.05          
Board of Director [Member] | BSA 2 [Member] | First Anniversary [Member]            
Disclosure of terms and conditions of share-based payment arrangement [line items]            
Vesting period (years) 1 year          
Plan expiration date Jan. 20, 2019          
Number of options granted 2,680          
Share entitlement per BSA2 | € / shares € 15          
Exercise price (in euros) € 65          
Valuation method used            
Grant date share fair value (in euros) € 70          
Expected volatility 40.00%          
Average life of BCE2010 (in years) 0          
Discount rate 2.71%          
Expected dividends 0.00%          
Fair value per BSA2 (in euros) € 30.32          
Board of Director [Member] | BSA 2 [Member] | Second Anniversary [Member]            
Disclosure of terms and conditions of share-based payment arrangement [line items]            
Vesting period (years) 2 years          
Plan expiration date Jan. 20, 2019          
Number of options granted 1,072          
Share entitlement per BSA2 | € / shares € 15          
Exercise price (in euros) € 65          
Valuation method used            
Grant date share fair value (in euros) € 70          
Expected volatility 40.00%          
Average life of BCE2010 (in years) 0          
Discount rate 2.98%          
Expected dividends 0.00%          
Fair value per BSA2 (in euros) € 31.89          
Board of Director [Member] | BSA 2 [Member] | Third Anniversary [Member]            
Disclosure of terms and conditions of share-based payment arrangement [line items]            
Vesting period (years) 3 years          
Plan expiration date Jan. 20, 2019          
Number of options granted 1,072          
Share entitlement per BSA2 | € / shares € 15          
Exercise price (in euros) € 65          
Valuation method used            
Grant date share fair value (in euros) € 70          
Expected volatility 40.00%          
Average life of BCE2010 (in years) 0          
Discount rate 2.98%          
Expected dividends 0.00%          
Fair value per BSA2 (in euros) € 33.05          
Board of Director [Member] | BSA 2 [Member] | Fourth Anniversary [Member]            
Disclosure of terms and conditions of share-based payment arrangement [line items]            
Vesting period (years) 4 years          
Plan expiration date Jan. 20, 2019          
Number of options granted 1,070          
Share entitlement per BSA2 | € / shares € 15          
Exercise price (in euros) € 65          
Valuation method used            
Grant date share fair value (in euros) € 70          
Expected volatility 40.00%          
Average life of BCE2010 (in years) 0          
Discount rate 3.11%          
Expected dividends 0.00%          
Fair value per BSA2 (in euros) € 33.45